BCEIE › News › MEDICO

Results

Medico Remedies: 1.Unaudited Standalone Financial Results for the quarter ended 30th September 2026 alongwith Auditors'…

Medico Remedies (MEDICO) filed a disclosure titled "1.Unaudited Standalone Financial Results for the quarter ended 30th September 2026 alongwith Auditors' Limited Review Report thereon; 2. The company is valued at about ₹149 crore.

BCEIE News Desk · Published 9 Nov 2026, 05:33 pm IST · Filing received 9 Nov 2026, 05:17 pm IST

What happened

Medico Remedies (MEDICO) filed a disclosure with the exchanges on 9 November 2026 at 05:17 PM titled "1.Unaudited Standalone Financial Results for the quarter ended 30th September 2026 alongwith Auditors' Limited Review Report thereon; 2. Appointment of M/s V. J. Talati & Co. as…".

Company snapshot

Medico Remedies is a micro-cap company, with a market value of about ₹149 crore.

The stock last traded at ₹17.99, against a 52-week range of ₹17.81–₹56.88 (68.4% below the high).

Before this filing the shares had moved −19.6% over the month and −62.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.35 crore.

Promoters held 61.38% at the end of Q1 FY27. Foreign institutions owned 0.08% and domestic institutions 0.00%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY26381.80.22
Q2 FY26532.60.31
Q3 FY26592.90.7
Q4 FY26575.90.71
Q1 FY27692.50.3

What history shows

BCEIE's records show 1 previous results filing from the company since May 2026.

Market-wide, 11,020 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 9 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.